LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel ; Online: Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome.

    Gu Urban, Gucci Jijuan / Friedman, Mikaela / Ren, Ping / Törn, Carina / Fex, Malin / Hampe, Christiane S / Lernmark, Åke / Landegren, Ulf / Kamali-Moghaddam, Masood

    Scientific reports

    2015  Band 5, Seite(n) 11196

    Abstract: Glutamic acid decarboxylase 65 (GAD65) and autoantibodies specific for GAD65 (GADA) are associated with autoimmune diseases including Stiff Person Syndrome (SPS) and Type 1 diabetes (T1D). GADA is recognized as a biomarker of value for clinical diagnosis ...

    Abstract Glutamic acid decarboxylase 65 (GAD65) and autoantibodies specific for GAD65 (GADA) are associated with autoimmune diseases including Stiff Person Syndrome (SPS) and Type 1 diabetes (T1D). GADA is recognized as a biomarker of value for clinical diagnosis and prognostication in these diseases. Nonetheless, it remains medically interesting to develop sensitive and specific assays to detect GAD65 preceding GADA emergence, and to monitor GADA-GAD65 immune complexes in blood samples. In the present study, we developed a highly sensitive proximity ligation assay to measure serum GAD65. This novel assay allowed detection of as little as 0.65 pg/ml GAD65. We were also able to detect immune complexes involving GAD65 and GADA. Both free GAD65 and GAD65-GADA levels were significantly higher in serum samples from SPS patients compared to healthy controls. The proximity ligation assays applied for detection of GAD65 and its immune complexes may thus enable improved diagnosis and better understanding of SPS.
    Mesh-Begriff(e) Adult ; Aged ; Antigen-Antibody Complex/blood ; Antigen-Antibody Complex/immunology ; Autoantibodies/immunology ; Case-Control Studies ; Female ; Glutamate Decarboxylase/blood ; Humans ; Immunoassay ; Male ; Middle Aged ; Peptide Fragments/blood ; Stiff-Person Syndrome/blood ; Stiff-Person Syndrome/immunology
    Chemische Substanzen Antigen-Antibody Complex ; Autoantibodies ; Peptide Fragments ; glutamate decarboxylase 65 (202-221) (EC 4.1.1.-) ; Glutamate Decarboxylase (EC 4.1.1.15)
    Sprache Englisch
    Erscheinungsdatum 2015-06-16
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/srep11196
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  2. Artikel: Integrative Personal Omics Profiles during Periods of Weight Gain and Loss.

    Piening, Brian D / Zhou, Wenyu / Contrepois, Kévin / Röst, Hannes / Gu Urban, Gucci Jijuan / Mishra, Tejaswini / Hanson, Blake M / Bautista, Eddy J / Leopold, Shana / Yeh, Christine Y / Spakowicz, Daniel / Banerjee, Imon / Chen, Cynthia / Kukurba, Kimberly / Perelman, Dalia / Craig, Colleen / Colbert, Elizabeth / Salins, Denis / Rego, Shannon /
    Lee, Sunjae / Zhang, Cheng / Wheeler, Jessica / Sailani, M Reza / Liang, Liang / Abbott, Charles / Gerstein, Mark / Mardinoglu, Adil / Smith, Ulf / Rubin, Daniel L / Pitteri, Sharon / Sodergren, Erica / McLaughlin, Tracey L / Weinstock, George M / Snyder, Michael P

    Cell systems

    2018  Band 6, Heft 2, Seite(n) 157–170.e8

    Abstract: Advances in omics technologies now allow an unprecedented level of phenotyping for human diseases, including obesity, in which individual responses to excess weight are heterogeneous and unpredictable. To aid the development of better understanding of ... ...

    Abstract Advances in omics technologies now allow an unprecedented level of phenotyping for human diseases, including obesity, in which individual responses to excess weight are heterogeneous and unpredictable. To aid the development of better understanding of these phenotypes, we performed a controlled longitudinal weight perturbation study combining multiple omics strategies (genomics, transcriptomics, multiple proteomics assays, metabolomics, and microbiomics) during periods of weight gain and loss in humans. Results demonstrated that: (1) weight gain is associated with the activation of strong inflammatory and hypertrophic cardiomyopathy signatures in blood; (2) although weight loss reverses some changes, a number of signatures persist, indicative of long-term physiologic changes; (3) we observed omics signatures associated with insulin resistance that may serve as novel diagnostics; (4) specific biomolecules were highly individualized and stable in response to perturbations, potentially representing stable personalized markers. Most data are available open access and serve as a valuable resource for the community.
    Mesh-Begriff(e) Adult ; Biomarkers/blood ; Genomics/methods ; Humans ; Insulin Resistance/genetics ; Male ; Metabolomics/methods ; Obesity/genetics ; Precision Medicine/methods ; Proteomics/methods ; Weight Gain/genetics ; Weight Loss/genetics
    Chemische Substanzen Biomarkers
    Sprache Englisch
    Erscheinungsdatum 2018-01-17
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2854138-8
    ISSN 2405-4720 ; 2405-4712
    ISSN (online) 2405-4720
    ISSN 2405-4712
    DOI 10.1016/j.cels.2017.12.013
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Volltext online

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

Zum Seitenanfang